Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2012
03/29/2012WO2012039513A1 Proliferation, separation and transplantation of suppressive neural progenitor cells, and substance capable of enhancing proliferation of the cells
03/29/2012WO2012039445A1 Method for producing cruciferous plant resistant to clubroot
03/29/2012WO2012039430A1 Method for isolating cancer stem cells
03/29/2012WO2012038668A1 Method for obtaining differentiated articular chondrocytes in vitro or ex vivo, and uses of same
03/29/2012WO2012038548A1 Thioesterases and their use
03/29/2012WO2012037642A1 System and method for automated sperm manipulation
03/29/2012WO2011159709A3 Photobioreactor system
03/29/2012WO2011142832A3 Stem cells derived under low oxygen conditions
03/29/2012WO2011119986A9 Methods for culturing and analyzing cells
03/29/2012US20120079628 Compositions and methods for modulation of plant cell division
03/29/2012US20120079626 Lipase polypeptide
03/29/2012US20120079620 Storage-induced promoter
03/29/2012US20120079619 Rice Cultivar Roy J
03/29/2012US20120079618 Bitter melon variety cbm12 and products therefrom
03/29/2012US20120079617 Pepper hybrid ps16364674
03/29/2012US20120079616 Npc1l1 (npc3) and methods of use thereof
03/29/2012US20120079615 Knock-in mice with inducible loss of eosinophils
03/29/2012US20120079613 Homeobox Transcription Factor BSX and Uses Thereof for Treating Diseases, in Particular Obesity
03/29/2012US20120079611 Tl1a model of inflammation fibrosis and autoimmunity
03/29/2012US20120077964 Antagonists of pcsk9
03/29/2012US20120077867 Compositions And Methods For Treating Pancreatic Cancer
03/29/2012US20120077866 Antisense modulation of c-reactive protein expression
03/29/2012US20120077863 Guanidino-substituted bi-and polyphenyls as small molecule carriers
03/29/2012US20120077862 Antisense modulation of ptp1b expression
03/29/2012US20120077861 Bispecific Antisense Oligonucleotides that Inhibit IGFBP-2 and IGFBP-5 and Methods of Using Same
03/29/2012US20120077854 Compositions and methods for modulating retinol binding to retinol binding protein 4 (rbp4)
03/29/2012US20120077843 Malignant precursor cells from ductal carcinoma in situ lesions
03/29/2012US20120077841 Methods for cancer therapy and stem cell modulation
03/29/2012US20120077806 Deubiquitinase Inhibitors and Methods for Use of the Same
03/29/2012US20120077759 3-3-Di-Substituted-Oxindoles as Inhibitors of Translation Initiation
03/29/2012US20120077758 Infertility associated defb-126 deletion polymorphism
03/29/2012US20120077757 Methods for Affecting Homology-Directed DNA Double Stranded Break Repair
03/29/2012US20120077731 Amino acid sequences directed against il-6r and polypeptides comprising the same for the treatment of il-6r related diseases and disorders
03/29/2012US20120077713 Collection and Methods for its Use
03/29/2012US20120077710 Method for an in vitro molecular evolution of antibody function
03/29/2012US20120077706 Method for assaying protein-protein interaction
03/29/2012US20120077273 Methods and Compositions for Limiting Viability of a Modified Host Cell Outside of Designated Process Conditions
03/29/2012US20120077272 Cellular scaffold
03/29/2012US20120077271 Differentiation of multi-lineage progenitor cells to chondrocytes
03/29/2012US20120077270 Control of Gene Expression Using a Complex of an Oligonucleotide and a Regulatory Peptide
03/29/2012US20120077269 Use of a protein in stem cell and cancer applications
03/29/2012US20120077268 Animal-free cell culture method
03/29/2012US20120077267 Device and method of separating cells by using magnetic force
03/29/2012US20120077263 Methods and materials for isolating exosomes
03/29/2012US20120077229 Compositions and methods relating to proteins requiring Gamma-Carboxylation
03/29/2012US20120077228 OVEREXPRESSION OF AMINOACYL-tRNA SYNTHETASES FOR EFFICIENT PRODUCTION OF ENGINEERED PROTEINS CONTAINING AMINO ACID ANALOGUES
03/29/2012US20120077226 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
03/29/2012US20120077224 unnatural amino acid incorporation in eukaryotic cells
03/29/2012US20120077213 Cell culture improvements
03/29/2012US20120077207 CD86 and CD80 receptor competition assays
03/29/2012US20120077204 Detection of Protein Translocation by Beta-Galactosidase Reporter Fragment Complementation
03/29/2012US20120077182 Additive solution for blood preservation
03/29/2012US20120077181 Method for the cryopreservation of cells, artificial cell constructs or three-dimensional complex tissues assemblies
03/29/2012US20120076853 Composition for use in gene therapy
03/29/2012US20120076851 CHROMOSOME 3p21.3 GENES ARE TUMOR SUPPRESSORS
03/29/2012US20120076830 Differentiation of stem cells with nanoparticles
03/29/2012US20120076827 Compositions and methods for generating an immune response in a subject
03/29/2012US20120076815 Identification and characterization of racemases, definition of protein signatures, and a test for detecting d-amino acid and for screening molecules capable of inhibiting the activity of racemase, especially proline racemase
03/29/2012US20120076805 Methods and Compositions for the Generation and Maintenance of Regulatory T Cells
03/29/2012US20120076803 Antibodies to troponin i and methods of use thereof
03/29/2012US20120076802 Human cytomegalovirus neutralising antibodies and use thereof
03/29/2012US20120076801 Human cytomegalovirus neutralising antibodies and use thereof
03/29/2012US20120076799 Antagonists of pcsk9
03/29/2012US20120076798 Antagonistic Human LIGHT-Specific Human Monoclonal Antibodies
03/29/2012US20120076792 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
03/29/2012US20120076789 Nucleic acid and corresponding protein entitled 121p1f1 useful in treatment and detection of cancer
03/29/2012US20120076786 Bispecific antibodies
03/29/2012US20120076785 Method for inhibiting neurodegeneration
03/29/2012US20120076780 Recombinant fusion protein and polynucleotide construct for immunotoxin production
03/29/2012US20120076778 Antibodies Against Insulin-Like Growth Factor I Receptor and Uses Thereof
03/29/2012US20120076777 Anti-fibroblastic fluorochemical emulsion therapies
03/29/2012US20120076764 Methods and pharmaceutical compositions for healing wounds
03/29/2012US20120076763 Combination anti-hiv vectors, targeting vectors, and methods of use
03/29/2012US20120076762 Induced pluripotent stem cell generation using two factors and p53 inactivation
03/29/2012US20120076761 Cloned ungulate embryos and animals, use of cells, tissues and organs thereof for transplantation therapies including Parkinson's disease
03/29/2012US20120076758 Antibodies against west nile virus and therapeutic and prophylactic uses thereof
03/29/2012US20120076730 Peptides for transport of therapeutics and their carriers in mouse models and humans
03/29/2012CA2812416A1 Human b1 cells and uses thereof
03/29/2012CA2812096A1 Oncolytic adenoviral vectors and methods and uses related thereto
03/29/2012CA2811878A1 Method for producing cruciferous plant resistant to clubroot
03/28/2012EP2434020A2 Method of producing minus strand RNA virus vector with the use of hybrid promoter containing cytomegalovirus enhancer and avian beta-actin promoter
03/28/2012EP2434019A1 Process for the production of fine chemicals
03/28/2012EP2434013A1 Promoter for introducing gene into lymphocyte or blood cell and application thereof
03/28/2012EP2434012A1 Vector material for creating pluripotent stem cells, and pluripotent stem cell creation method using said vector material
03/28/2012EP2434011A1 Glucosyltransferase specific to position-4 of furofuran-type lignan, and polynucleotide encoding same
03/28/2012EP2434007A1 Method for inducing differentiation of embryonic stem cells or artificial pluripotent stem cells
03/28/2012EP2433642A2 Modified proteases that inhibit complement activation
03/28/2012EP2432886A1 Method and system for somatic cell nuclear transfer
03/28/2012EP2432871A1 Synthetic graft
03/28/2012EP2432870A1 Compositions and methods to prevent cancer by stabilizing p53 through non mdm2-mediated pathways
03/28/2012EP2432481A2 Cell therapy for brain tissue damage
03/28/2012EP2432421A1 Ultrasound technology to control the spatial organization of cells and proteins in engineered tissues
03/28/2012EP2068614B1 Method and device for micropropagation of plants
03/28/2012EP2066349B1 Humanized anti-cd19 antibodies and their use in treatment of tumors, transplantation and autoimmune diseases
03/28/2012EP1959011B1 High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of matrix attachment region sequences
03/28/2012EP1906729B1 Plasma-depleted, non-red blood cell-depleted cord blood compositions and methods of use
03/28/2012EP1771196B1 Ccr ligands for stem cell homing
03/28/2012EP1517700B1 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
03/28/2012EP1326984B1 Cytochrome p450 monooxygenases consisting of thermophilic bacteria
03/28/2012EP1181318B2 Monoclonal antibodies, synthetic and biotechnological derivatives thereof acting as ngf-antagonist molecules
1 ... 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 ... 1827